Asynchrony of the central and the peripheral circadian clocks was associated with reducing insulin and glucagon-like peptide 1 (GLP-1) secretion (45), insulin resistance, β-cell proliferation, and β-cell apoptosis (44). The gene discussed is INS; the disease is Insulin resistance.